MOTIVATION: In the human genome, 'CpG islands', CG-rich regions located in or near gene promoters, are normally unmethylated. However, in cancer cells, CpG islands frequently gain methylation, resulting in silencing of growth-limiting tumor suppressor genes. To our knowledge, the potential relationship between CpG island hypermethylation, transcription factor (TF) binding in local promoter regions and transcriptional control has not been previously explored in a genome-wide context. RESULTS: In this study, we utilized bioinformatics tools and TF binding site(TFBs) databases to globally analyze sequences methylated in a laboratory model for the development of drug-resistant cancer. Our results demonstrated that four TFBS were enriched in hypermethylated sequences. More interestingly, overrepresentation of these TFBS was observed in hyper-/hypo-methylated sequences where signi.cant changes in methylation levels were observed in drug-resistant cancer cells. In summary, we believe that these.ndings offer a means to further explore the relationship between DNA methylation and gene expression in drug resistance and tumorigenesis.
MOTIVATION: In the human genome, 'CpG islands', CG-rich regions located in or near gene promoters, are normally unmethylated. However, in cancer cells, CpG islands frequently gain methylation, resulting in silencing of growth-limiting tumor suppressor genes. To our knowledge, the potential relationship between CpG island hypermethylation, transcription factor (TF) binding in local promoter regions and transcriptional control has not been previously explored in a genome-wide context. RESULTS: In this study, we utilized bioinformatics tools and TF binding site(TFBs) databases to globally analyze sequences methylated in a laboratory model for the development of drug-resistant cancer. Our results demonstrated that four TFBS were enriched in hypermethylated sequences. More interestingly, overrepresentation of these TFBS was observed in hyper-/hypo-methylated sequences where signi.cant changes in methylation levels were observed in drug-resistant cancer cells. In summary, we believe that these.ndings offer a means to further explore the relationship between DNA methylation and gene expression in drug resistance and tumorigenesis.
Authors: P LouAnn Cable; Cindy A Wilson; Frank J Calzone; Frank J Rauscher; Ralph Scully; David M Livingston; Leping Li; Courtney B Blackwell; P Andrew Futreal; Cynthia A Afshari Journal: Mol Carcinog Date: 2003-10 Impact factor: 4.784
Authors: Yu-Wei Leu; Pearlly S Yan; Meiyun Fan; Victor X Jin; Joseph C Liu; Edward M Curran; Wade V Welshons; Susan H Wei; Ramana V Davuluri; Christoph Plass; Kenneth P Nephew; Tim H-M Huang Journal: Cancer Res Date: 2004-11-15 Impact factor: 12.701
Authors: Robin P Smith; Jessica K Lerch-Haner; Jose R Pardinas; William J Buchser; John L Bixby; Vance P Lemmon Journal: Mol Cell Neurosci Date: 2010-08-07 Impact factor: 4.314
Authors: Derek M Murphy; Patrick G Buckley; Kenneth Bryan; Sudipto Das; Leah Alcock; Niamh H Foley; Suzanne Prenter; Isabella Bray; Karen M Watters; Desmond Higgins; Raymond L Stallings Journal: PLoS One Date: 2009-12-04 Impact factor: 3.240
Authors: Mingxiang Teng; Curt Balch; Yunlong Liu; Meng Li; Tim H M Huang; Yadong Wang; Kenneth P Nephew; Lang Li Journal: PLoS One Date: 2012-03-06 Impact factor: 3.240
Authors: Meng Li; Curt Balch; John S Montgomery; Mikyoung Jeong; Jae Hoon Chung; Pearlly Yan; Tim H M Huang; Sun Kim; Kenneth P Nephew Journal: BMC Med Genomics Date: 2009-06-08 Impact factor: 3.063